Cannabis Law Report

FEBRUARY 13, 2022

The Program Specialist 2 (Cannabis) positions will perform applicant and licensee inspection of physical facilities, adherence to program regulations, development of guidance documents and statement of findings and other duties ensuring licensees are complying with public health and safety best practices. Additional Comments.

Programs 52

Programs Research and Development Seed-To-Sale Compliance 52

Cannabis Law Report

MARCH 7, 2020

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71

Hemp CBD Research and Development Safety 71

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. . About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Cannigma

DECEMBER 20, 2021

Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. These methods may include: regular consumption inhalation oral administration local treatment via topical products. But how does cannabis actually affect the skin?

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Canna Law Blog

JULY 25, 2019

For the past six months, the federal agency has been bombarded with messages, urging the FDA to promptly develop a regulatory pathway for the lawful use of hemp-derived CBD (“Hemp-CBD”) in foods and dietary supplements. The Food and Drug Administration (“FDA”) seems to be listening.

CBD 98

CBD Research and Development Hemp Food 98

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. The Harris Poll is one of the longest running surveys in the U.S.

Safety 52

Safety Research and Development Compliance Compliance 52

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. . About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

MARCH 19, 2020

This advisory provides an overview of key regulatory activity and priorities that should be on the radar of any company engaged in the development or sale of products that contain CBD. In the absence of federal action, states have developed their own regulatory schemes. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

AUGUST 3, 2021

In addition to FDM and e-commerce, the Transaction provides added distribution channels, increasing HempFusion’s 5 channel strategy to 6 channels and bolstering topical product distribution sales. With a strong focus on research and development, HempFusion has an additional 30 products under development.

Research and Development 105

Research and Development Topical Events Compliance 105

The Cannigma

AUGUST 24, 2021

The Jointly database includes a very comprehensive assortment of flower stains, edibles, concentrates, tinctures, and topicals, and vows that “if it’s legal, we include it on our platform for the benefit of our community.”. The feedback is gathered and used to provide tailor made recommendations for products and doses. Learn More.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

The Cannigma

JULY 3, 2023

The clues we have from existing literature indicate that while it’s probably safe, there’s insufficient clinical research to confirm or dispel it. Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future.

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

JANUARY 12, 2022

In accordance with FDA requirements, an independent panel of qualified experts reviewed HempFusion’s safety dossier on its hemp-derived CBD extract, which included safety and toxicology studies, the published results of these studies, and a comprehensive review of the scientific literature on CBD. HempFusion Wellness Inc.

Retail 52

Retail CBD Extraction Research and Development 52

The Cannigma

FEBRUARY 16, 2021

There is not extensive safety data available, however. They can also improve the penetration of topical solutions through skin lipids. Hundreds if not thousands of hours of experimentation and development may be required, and doing so “at a large scale with precision is not just science but an art form,” he added.

Edibles 137

Edibles Digestion Tincture Cannabinoids 137

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., CBD is marketed in a variety of product types, such as oil drops, capsules, syrups, teas and topical lotions and creams.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

AUGUST 27, 2021

Built on a foundation of regulatory compliance and human safety, HempFusion Wellness offers a diverse product portfolio comprising of over 75 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more.

Research and Development 105

Research and Development Events Hemp Food 105

The Blunt Truth

AUGUST 13, 2019

The following is a brief update on recent developments within the federal regulatory regime of CBD products. . On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. FDA’s Regulatory Efforts.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

JUNE 1, 2021

.” 1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Data 95

Data Vaping Supply Chain Business 95

CannaMD

DECEMBER 9, 2020

This comprehensive document includes both a general summary of current research on cannabis use and more specific findings on its role in cardiovascular health and health risks. The AHA position paper then moves on to address a range of known, potential, and suggested safety concerns associated with cannabis use. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

AUGUST 25, 2021

The #1 brand in CBD topicals, with 23% market share in the Drug channel [Drug (IRI-SPINScan 52 week ending 7-11-2021)] and 13.8-per-cent With a strong focus on research and development, HempFusion has an additional 30 products under development. pull week ending 5/22/21)].

Retail 111

Retail Supply Chain Research and Development Events 111

Cannabis Law Report

OCTOBER 29, 2021

The primary endpoint of this Phase 1 trial was safety and tolerability. We expect to report this data as it becomes available and after submission to the FDA. in thousands, except share data). . . . in thousands, except loss per share and share data). . . Research and development expenses. . .

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Alongside the Core Business, we remain agile and innovative, developing new solutions to fight the pandemic. In Sweden, Eurofins developed a new automated and robotised PFAS testing method supporting the lowest detection limits globally.

Business 105

Business Research and Development Environment Food 105

TheAnswerPage

JANUARY 11, 2022

Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop? Unfortunately, this did not occur. Medical marijuana, unlike every other legal medication in the US, has been legalized by the vote of the public and the work of policymakers.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

AUGUST 16, 2021

HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to over approximately 15,000 retail locations across all 50 states of the United States and select international locations.

eCommerce 105

eCommerce Retail Research and Development CBD 105

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? Research suggests that about one in five people will have an increase in paranoia as a result of the delta-9 THC after consuming cannabis.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

The Cannigma

JULY 9, 2023

The short answer, according to the existing scientific research, is maybe, and it depends. To properly answer this question we need to first look at what we know about cannabis and development in general. Is the ECS involved in development? 6 Does cannabis impact brain development? Let’s talk neurology.

Research and Development 68

Research and Development THC Cannabinoids Topical 68

Canna Law Blog

SEPTEMBER 6, 2023

We recently wrote about three facts and myths from this massive development, but in this post I want to cover what I think legal cannabis looks like in the U.S. 280E from their business plans and medical research will finally open up, I think the longer game ultimately spells trouble for our current state-legal cannabis industry.

Research and Development 113

Research and Development DEA Marijuana Pharmaceutical 113

The Cannigma

OCTOBER 6, 2022

Cannabis use and pregnancy is a tough topic. The unknown effects of cannabis on developing babies are concerning enough to bring pause to the medical community and usually results in a firm recommendation to avoid all cannabis during pregnancy. Limited research on CBD and pregnancy. The risks of substances during pregnancy.

CBD 99

CBD Research and Development Topical THC 99

The Cannigma

DECEMBER 1, 2021

A comprehensive 2015 review of more than two decades of research found that individuals who try cannabis are less likely to develop a dependency than users of almost any other substance, including nicotine, heroin, cocaine, alcohol or stimulants. In contrast, the likelihood of developing a dependence on nicotine was a whopping 32%.

Research and Development 103

Research and Development Tincture THC Cannabinoids 103

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1]

CBD 98

CBD Chronic Pain Oil Topical 98

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1]

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Among animal research, it’s clear that CBD can reduce pain and inflammation in various models of pain, including neuropathic pain, inflammatory pain, and arthritis-related pain.[1]

CBD 52

CBD Chronic Pain Oil Topical 52

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country. Excise taxes.

Vaping 105

Vaping Research and Development Data Business 105